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ABSTRACT
Background: Stomal leaks can be associated
with significant social, psychological and
physical morbidity for ostomy patients. Poor
fitting of the stoma appliance due to
irregularities of skin contours is one cause of
stoma leaks which commonly result in
secondary irritant dermatitis prompting
presentation to a dermatologist. In addition to
skin-directed topical therapy and review of
stoma appliances, correction of contour
defects with intradermal injections of filler
materials is one possible treatment to improve
adhesion and reduce leaks.
Cases: We report eight cases of ostomy
patients, who presented with stoma leaks and
associated dermatitis, who were treated with
intradermal injections of the porcine collagen
(PermacolTM) or subcutaneous injections of
polyacrylamide hydrogel (Aquamid
ReconstructionTM) for correction of skin
contour defects. Resolution or improvement of
symptoms was achieved for five patients, and
no complications were noted as a result of
treatment.
Conclusions: This report represents the largest
series of ostomy patients treated for correction
of peristomal skin contour defects with injection
therapy. Treatment was well tolerated and
performed in the outpatient setting under local
anesthetic. Attempted correction of peristomal
skin contour defects using injection of filler
materials represents a potential alternative to
surgical intervention and can result in
significant benefits for the patient.
Keywords: Collagen; Colostomy; Filler;
Ileostomy; Polyacrylamide hydrogel; Porcine
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INTRODUCTION
Indications for stoma formation most
commonly comprise; malignancy,
inflammatory bowel disease, neurological
dysfunction and trauma. Ileostomies,
colostomies and urostomies are the most
common types of stoma. The number of stoma
patients in the United Kingdom (UK) is
unknown, but has been estimated to be above
100,000 [1].
Peristomal skin problems are common
affecting up to 73% of ostomates [2].
Peristomal irritant dermatitis is the most
frequent skin complication and can be both a
cause and a consequence of poor adhesion of
stoma appliances associated with leakage of
stoma contents [3]. Leakage of stoma contents
is common affecting up to 62% of ostomates
and can be associated with considerable social,
psychological and physical morbidity [4, 5].
Irregularities of the skin surface contours
surrounding stoma sites are one cause of poor
appliance adhesion and leaks. Such
irregularities can arise through remodeling of
the skin, pressure from stoma devices, change in
body habitus or adjacent scar tissue. Changes to
skin surface contours can arise early after stoma
formation or as a late complication many years
after formation. Regular review of stoma
appliances, dressings or use of filler pastes can
be used to compensate for alterations in skin
surface contours, but are not successful in all
cases [6].
Individual case reports have described
correction of skin surface contour irregularities
by injection of bovine [7] or porcine [8] collagen
as a treatment option to improve appliance
adhesion and prevent leakage.
We have run a joint stoma-care and
dermatology clinic each month in Salford
Royal hospital for the last 15 years. It is staffed
by the same dermatologist who is regularly
involved in their care, 2 stoma nurse specialists
and 1 or 2 dermatologists in training. All
patients get a full dermatological and ostomy
nurse assessment, advice and management plan
[2]. There are also weekly open access clinics so
that patients can attend without further referral
from their own clinician and be seen in the
joint clinic if there are problems.
We report a further eight cases of patients,
from our clinic with persistent stoma leaks, who
were treated with injection of either temporary
or permanent filler as a means of correcting skin
surface contour defects.
All patients had already tried a variety of
appliance modifications without success prior
to the use of subcutaneous fillers. These
included convex appliances, topical filler
pastes (karaya and/or carboxymethylcellulose)
or hydrocolloid strips, additional hydrocolloid
washers (rings) and barrier films (silicon or
acrylate based).
CASE REPORTS
All procedures followed were in accordance
with the ethical standards of the responsible
committee on human experimentation
(institutional and national) and with the
Helsinki Declaration of 1975, as revised in
2000 and 2008. Informed consent was
obtained from all patients for being included
in the study.
Patient 1
A 48-year-old woman with Crohn’s disease and
a long-standing ileostomy presented with
persistent peristomal skin irritation and stoma
leaks not responsive to change in her stoma
appliances or use of filler pastes. On
examination, she had a peristomal
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psoriasiform dermatitis and her stoma was sited
near a tethered appendectomy scar with
peristomal skin depressions.
A total of 12 ml of porcine collagen,
PermacolTM (Tissue Science Laboratories plc,
Aldershot, Hampshire, United Kingdom), was
injected intradermally during three procedures
over a 7-month period. Each procedure was
performed under local anesthesia and post-
procedural antibiotics were given with
ciprofloxacin 250 mg twice daily for 3 days. No
complications were noted. Additional topical
therapy with betamethasone dipropionate
0.05% and calcipotriol (Dovobet, Leo
Pharmaceuticals, Buckinghamshire, United
Kingdom) and localized narrowband UVB was
applied with clearance of the dermatitis and
resolution of the leaks. She has had no further
problems with leakage or dermatitis over the
subsequent 4 years.
Patient 2
A 71-year-old patient with a urostomy formed
in 1997 following failed clam cystoplasty
presented to dermatology in November 2005
with persistent stoma leaks. On examination,
she had peristomal irritant dermatitis and
prominent skin guttering at the 3 and 9
o’clock positions around her stoma.
Between March 2006 and August 2010, she
underwent repeated intradermal injection of
porcine collagen to the affected areas (*24 ml
in total). Volumes of between 1.5 and 3.0 ml
were injected to each site as needed under local
anesthesia at 2–6 monthly intervals. No
additional post-procedural antibiotics were
required as the patient was maintained on
rotational antibiotic therapy for recurrent
urinary tract infections.
Treatment resulted in improvement in
leakage and accompanying dermatitis, but
with recurrence after 2–3 months. In March
2010, she underwent treatment with
subcutaneous injection of 2.5 ml of
polyacrylamide hydrogel, AquamidTM
(Contura UK Ltd, London, United Kingdom),
divided between the affected areas with
repeated 1 ml injection of one site 3 months
later. This did not produce significant
improvement and she has reverted to porcine
collagen injections to prevent leaks. These
continue to be required approximately every
6 months.
Insertion of polyacrylamide hydrogel was
followed by post-procedural antibiotics with
ciprofloxacin 250 mg twice daily for 3 days.
There has been marked improvement in the
degree of leakage and she remains under review
with repeated treatment with collagen
injections every 6 months.
Patient 3
A 41-year-old patient with a long-standing
colostomy and urostomy following treatment
for cervical carcinoma in 1988 presented to the
stoma clinic in February 2009 with repeated
leaks from her colostomy bag. On examination,
she had psoriasiform peristomal dermatitis
surrounding both stoma sites and a deep skin
depression at the 6 o’clock position of her
colostomy.
Between March 2009 and July 2009, she
underwent intradermal injection of 7 ml of
porcine collagen in divided doses in addition
to topical therapy with betamethasone valerate
0.1% scalp lotion (Betnovate scalp lotion,
GlaxoSmithKline, Uxbridge, United Kingdom).
Each procedure was performed under local
anesthesia and post-procedural antibiotics were
given with ciprofloxacin 250 mg twice daily for
3 days. Control of her dermatitis was achieved
with maintenance topical therapy, however,
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there was no improvement to the skin
depression and she continued to experience
leaks. She was referred for surgical refashioning
of her stoma.
Patient 4
In July 2007, a 21-year-old Jehovah’s witness, a
belief that precludes any transfusion of blood
products, with a background diagnosis of
Crohn’s disease and an ileostomy since 1999
was referred with recurrent stomal leaks. She
had already required re-siting of her stoma on
more than ten occasions due to recurrent
retraction and leakage. On examination, she
had bilateral peristomal guttering with
significant leakage.
Between September of 2007 and April of
2008, she underwent three intradermal
injections of porcine collagen totaling 9 ml.
Unfortunately, her symptoms did not improve
and she was referred for surgical re-siting of her
stoma.
Patient 5
A 64-year-old patient with known Peutz-
Jegher’s syndrome and long-standing
ileostomy was referred with recurrent stomal
leaks due to muscular contraction of the
abdominal wall and apparent contractility of
the stoma. There was no response to botulinum
toxin injection into the stoma musculature. He
was noted to have a pronounced area of
guttering at the right lower margin of the
stoma which was injected with 2.5 ml of
porcine collagen. His symptoms improved and
no further treatment was needed. To minimize
the risk of further leaks, he has continued to use
a hydrocolloid washer under the appliance and
has had no further problems after 4 years
follow-up.
Patient 6
A 23-year-old patient with known Crohn’s
disease and an ileostomy refashioned in 2004
developed recurrent leaks from her stoma
*2 years after the original surgery. Clinically
she had a deep, crescent-shaped depression on
the inferior margin of her stoma complicated by
excess mucous formation.
She received 1 ml of intradermal porcine
collagen to each side of the depression and was
given 5 days of post-procedural prophylaxis with
erythromycin. Two months after the procedure,
there was complete resolution of the depression
with significant improvement in symptomology.
She had only occasional bag failures after
treatment resulting in dermatitis but has not
required any further treatment 4 years later.
Patient 7
A 52-year-old patient with a background history
of pyocystitis originally had a urostomy formed
in 1999. She was referred in March of 2005,
3 years after formation of her current urostomy,
suffering from recurrent leakage. Clinically she
had a discernible valley-like circumferential
depression around her stoma. This became
more pronounced on sitting forward due to
muscular tension on the skin.
In total, she received two injections of
intradermal porcine collagen totaling 5 ml.
Although ‘plumping up’ of the skin was
observed post-procedure, this was transient
and there was no improvement in her
symptoms. She was referred for surgical re-
siting of her stoma.
Patient 8
A 28-year-old man with a background history of
Hirschsprung’s disease presented with recurrent
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leakage from his long-standing ileostomy. His
symptoms had required him to give up
swimming and were causing him significant
distress.
On examination, he had a skin groove
medial to his stoma secondary to an adjacent
scar. He underwent subcision of the scar under
local anesthetic followed 1 week later by
subcutaneous injection of 4 ml of
polyacrylamide hydrogel. At review after
1 year, he has remained leak-free and been
able to recommence regular swimming. He no
longer suffers any dermatitis as a result, see
Fig. 1.
COMMENT ON CASES
We considered treatment to be a complete
success if the patient no longer suffered bag
failures with leakage and subsequent dermatitis
and without using any accessory products
(patients 1 and 8). Significant improvement
was recorded in three others where the patient
continued to require some additional treatment
either repeated injections (patient 2) or external
hydrocolloid washer to maintain bag adhesion
(patient 5); or because they have had very
occasional bag failure not requiring further
collagen injection (patient 6). The cost per
syringe for the fillers is *350 USD. We have
previously described the cost savings made by
reducing wasted appliances using botulinum
toxin in patients with contractile stomas who
presented with up to three bag failures per day
(A novel use for botulinum toxin A in the
management of ileostomy and urostomy leaks
[9]). We did not formally record frequency of
bag failures for patients before and after
collagen treatments because we began to use
Fig. 1 Case 8 a Pre-treatment medial peristomal groove.
b Immediately post-injection of porcine collagen and c at
review 1 year after injection of polyacrylamide hydrogel
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this therapy as an extension of our normal
practice using it in other conditions such as
subcutaneous fat atrophy. We are therefore not
able to be precise about costs in the current
cases, however cost benefits are likely to be
comparable as, although botulinum toxin is
cheaper per unit, more treatments are required
and over a longer period of time than for fillers.
DISCUSSION
Since the nineteenth century, a growing range of
autologous and synthetic materials have been
used for soft tissue augmentation [10]. Fillers are
categorized by origin (autologous, xenologous or
synthetic), duration (temporary, permanent or
semi-permanent), composition (e.g., collagen,
hyaluronic acid, polymethyl methacrylate etc.)
and by their intended location within the soft
tissues (e.g., subcutaneous or intradermal) [11].
Fillers are used in a wide range of medical and
cosmetic procedures including skin
rejuvenation, scar correction and treatment of
lipoatrophy [10, 12].
Porcine collagen is available as an injectable
suspension or as solid sheets. The suspension
form has been widely used in esthetic soft tissue
augmentation and demonstrates a favorable
side-effect profile [13]. Clinical use in the
treatment of fecal incontinence has been
attempted, but is currently of unproven
efficacy [14]. Preservation of cosmetic effect
depends on successful intradermal injection as
subcutaneously placed collagen rapidly
dissipates and superficially placed injections in
thin skin can cause unsightly blebs [10].
Polyacrylamide hydrogel, an implant which
is injected subcutaneously has been in clinical
use for over 20 years and appeared under the
brand name AquamidTM in 2000. It is non-toxic
[15] and a 5-year follow-up study by Pallua and
Wolter in patients receiving Polyacrylamide
hydrogel for facial soft tissue augmentation
showed persistent effect and a favorable safety
profile [16]. Minor adverse events following
injection included hematomas, pain,
discoloration and edema. Infection occurred in
four patients (2%) of which two were classified
as serious. The authors did not recommend
prophylactic antibiotics in the setting of facial
soft tissue reconstruction [17]. In our
experience of treating Parry–Romberg
syndrome, Polyacrylamide hydrogel
administration as an outpatient procedure was
well tolerated and provided sustained
improvement to facial contour asymmetry [16].
Autologous fat transfer (AFT) is an
alternative to the use of synthetic fillers;
however, its use is associated with significant
dissipation of the transferred material and a
higher rate of complications [18]. AFT has not
been described as a treatment for correction of
stoma contour defects. Liposuction contouring
risks damaging the stoma tract.
Individual case reports describing the use of
injected porcine or bovine collagen treatments
of peristomal skin contour defects have been
described by Smith et al. [8] and Arai et al. [7].
To our knowledge, this report represents the
largest single series of patients reported and the
first report of the use of permanent fillers for the
treatment of stoma leaks.
Smith et al. [8] described a patient who
developed leaking of his ileostomy due to an
increase in body habitus leading to peristomal
striae formation and irregularities of the skin
surface. Resolution of the leaks was obtained
after one injection of an unspecified amount of
porcine collagen under general anesthetic. No
post-procedural antibiotics were administered
and no complications were noted following the
procedure or after 2 years of follow-up.
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Arai et al. [7] described a patient in whom
two injections of bovine collagen were applied
for correction of paraurostomy skin
abnormalities. They applied a small amount of
bovine collagen to a test site remote from the
area for treatment 1 month before the first
procedure and supplied 3 days of post-
procedural antibiotics. A total of 5 ml of
collagen was injected without anesthetic
during two procedures 3 months apart. No
adverse events were noted.
Our patients were all long-standing
ostomates who had developed skin contour
defects months to years after the formation of
their stomas. This may have been due to skin
remodeling around the stoma or of surrounding
scar tissue. Patient characteristics are
summarized in Table 1.
In each case, poor appliance adhesion had
led to the development of leaks and secondary
skin changes. In one case, persistent irritation
led to the formation of peristomal psoriatic
plaques through Koebnerization. Prevention of
stoma leakage led to improvement in the skin
and patient quality of life manifesting as
confidence to take up social activities such as
swimming.
The amount of filler material required varied
considerably between cases and some patients
required repeated treatments. Unfortunately,
not all patients experienced resolution of their
symptoms and three cases required surgical
refashioning of the stoma. Skin contour
defects were exaggerated in obese patients
were leaning forward created deep skin folds.
We did not find these amenable to treatment
with injectable filler therapy because of the
large volumes that would be required and the
tendency for the material to dissipate (patient
7). However, trial of injection therapy is still a











1 48 Ileostomy Porcine collagen 3 12 Resolution of symptoms
2 71 Urostomy Porcine collagen and
polyacrylamide
hydrogel
N/R 24 Transient improvement only
with polyacrylamide hydrogel.
Patient has continued to
require porcine collagen twice
yearly (1.5 ml to each of 2
parastomal depressions)
2 3.5
3 41 Colostomy Porcine collagen N/R 7 No improvement
4 21 Ileostomy Porcine collagen 3 9 No improvement
5 64 Ileostomy Porcine collagen 1 2.5 Resolution of symptoms
6 23 Ileostomy Porcine collagen 2 2 Resolution of symptoms
7 52 Urostomy Porcine collagen 2 5 No improvement
8 28 Ileostomy Polyacrylamide
hydrogel
1 4 Resolution of symptoms
N/R Not recorded
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valid recourse particularly in cases such as
patient 4, where religious beliefs, prior surgery
or other comorbidities increase the risks of
surgery. In cases where improvement was
transient, loss of effect could be explained by
dissipation of porcine collagen, and
substitution of a permanent filler improved
efficacy.
Though prophylactic antibiotics are not
routinely recommended following the
application of fillers for facial soft tissue
augmentation, the peristomal environment
and potentially serious consequences of
infection suggest that post-procedural
antibiotics should be considered on a case-by-
case basis. No complications were observed
from the treatment or as a consequence of
antibiotic therapy.
It is our experience that peristomal
intradermal or subcutaneous injection of filler
materials was well tolerated when performed
under local anesthesia in an outpatient setting.
CONCLUSION
Leakage of stoma contents is a common and
potentially disabling problem for ostomates
which may result in, or from, disorders of the
peristomal skin. Multidisciplinary management
of such patients with input from specialist
stoma nurses, surgeons and dermatologists
should be instituted to optimize appliances
and manage skin disease. Irregularities in the
peristomal skin surface contours may
contribute to poor appliance adhesion and
should be sought during evaluation.
This report highlights intradermal injection
of fillers as a potential treatment for the
correction of skin surface contour defects.
Treatment can correct skin contour defects
improving appliance adhesion and aiding the
resolution of associated skin disease. As such
intradermal injection of fillers, such as porcine
collagen and polyacrylamide hydrogel,
represents a valuable alternative to surgical
intervention.
Patient selection is very important, and
experience with this small cohort of patients
suggests that it is not likely to be effective in
those with obese abdomens and/or very deep
defects in prominent abdominal folds. In
contrast, relatively small, localized defects
respond more readily to treatment (see case 8,
Fig. 1).
Dermatologists are well placed to provide
such therapy which is heavily dependent on
appropriate technique and correct placement of
injected material. Our experience suggests that
peristomal intradermal or subcutaneous
injections are well tolerated when performed
under local anesthetic in the outpatient setting.
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